Sort by
Refine Your Search
-
gastrointestinal (GI) and rare diseases. Ironwood is advancing apraglutide, a next-generation, long-acting synthetic GLP-2 analog being developed for short bowel syndrome patients who are dependent on parenteral
-
Pharmaceuticals is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI) and rare diseases. Ironwood is advancing apraglutide, a next-generation
-
. Company Summary: Ironwood Pharmaceuticals is a leading global gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients
-
: Ironwood Pharmaceuticals is a leading global gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients. We are pioneers
-
Ph.D. in any aspects of climate and/or sustainability, with either by a PhD degree in any aspect of climate and/or sustainability sciences and engineering (e.g., to coincide with one of the five themes
-
) to evaluate novel biomarkers for ADRD. Minimum Qualifications - PhD in computer science, engineering, bioinformatics, biomedical data science, or related field - Familiarity with genomic and bioinformatic
-
of October 31, 2025: 1. Curriculum vitae (CV), uploaded 2. Unofficial PharmD/PhD transcripts, uploaded 3. Cover letter, uploaded Three formal letters of recommendation (LORs) should be sent directly from the
-
disseminating results via conferences, talks, and first-author manuscripts. Expertise in any or all of these skills is not required. Qualifications: Applicants should have a PhD degree (or expected by September 1
-
from U.S. PhD degree candidates Additional Information Applicants should submit the following application materials by the priority deadline of October 31, 2025: 1. Curriculum vitae (CV), uploaded 2
-
U.S. PhD degree candidates Additional Information Applicants should submit the following application materials by the priority deadline of October 31, 2025: 1. Curriculum vitae (CV), uploaded 2